Uncommon Anal Neoplasms

Amitesh C. Roy; David Wattchow; David Astill; Simron Singh; Susan Pendlebury; Kirsten Gormly; Eva Segelov

doi:10.1016/j.soc.2016.07.009

Uncommon Anal Neoplasms

Amitesh C. Roy, David Wattchow, David Astill, Simron Singh, Susan Pendlebury, Kirsten Gormly, Eva Segelov

Research output: Contribution to journal › Review article › peer-review

12 Citations (Scopus)

Abstract

Anal cancer is a rare disease with epidermoid cancers accounting for 1% to 2% of all digestive tract malignancies.1Less common anal neoplasms comprise approximately 20% to 25% of these,2including anal canal adenocarcinoma, anorectal melanoma,mesenchymal and neurogenic tumors of the anal canal (in particular gastrointestinal stromal tumors [GIST], schwannomas, and sarcomas), neuroendocrine tumors (NETs),lymphoma, and basal cell carcinoma (BCC). The anal canal is also a rare site for metastasis from other primary malignancies. As imaging technology improves, particularly MRI, and colonoscopy becomes routine, many rarer tumors are detected incidentally.Diligent linkage of clinical features with expert histopathology assessment identifies uncommon anal neoplasms to ensure that appropriate management is instituted.

Original language	English
Pages (from-to)	143-161
Number of pages	19
Journal	Surgical Oncology Clinics of North America
Volume	26
Issue number	1
DOIs	https://doi.org/10.1016/j.soc.2016.07.009
Publication status	Published - Jan 2017

Keywords

Anal lymphoma
Anal melanoma
Anal neuroendocrine tumor
Unusual cancers

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.soc.2016.07.009Licence: In Copyright

Cite this

@article{0e56408106d049b0ade3f19b88ba16eb,

title = "Uncommon Anal Neoplasms",

abstract = "Anal cancer is a rare disease with epidermoid cancers accounting for 1% to 2% of all digestive tract malignancies.1Less common anal neoplasms comprise approximately 20% to 25% of these,2including anal canal adenocarcinoma, anorectal melanoma,mesenchymal and neurogenic tumors of the anal canal (in particular gastrointestinal stromal tumors [GIST], schwannomas, and sarcomas), neuroendocrine tumors (NETs),lymphoma, and basal cell carcinoma (BCC). The anal canal is also a rare site for metastasis from other primary malignancies. As imaging technology improves, particularly MRI, and colonoscopy becomes routine, many rarer tumors are detected incidentally.Diligent linkage of clinical features with expert histopathology assessment identifies uncommon anal neoplasms to ensure that appropriate management is instituted.",

keywords = "Anal lymphoma, Anal melanoma, Anal neuroendocrine tumor, Unusual cancers",

author = "Roy, {Amitesh C.} and David Wattchow and David Astill and Simron Singh and Susan Pendlebury and Kirsten Gormly and Eva Segelov",

year = "2017",

month = jan,

doi = "10.1016/j.soc.2016.07.009",

language = "English",

volume = "26",

pages = "143--161",

journal = "Surgical Oncology Clinics of North America",

issn = "1055-3207",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Uncommon Anal Neoplasms

AU - Roy, Amitesh C.

AU - Wattchow, David

AU - Astill, David

AU - Singh, Simron

AU - Pendlebury, Susan

AU - Gormly, Kirsten

AU - Segelov, Eva

PY - 2017/1

Y1 - 2017/1

N2 - Anal cancer is a rare disease with epidermoid cancers accounting for 1% to 2% of all digestive tract malignancies.1Less common anal neoplasms comprise approximately 20% to 25% of these,2including anal canal adenocarcinoma, anorectal melanoma,mesenchymal and neurogenic tumors of the anal canal (in particular gastrointestinal stromal tumors [GIST], schwannomas, and sarcomas), neuroendocrine tumors (NETs),lymphoma, and basal cell carcinoma (BCC). The anal canal is also a rare site for metastasis from other primary malignancies. As imaging technology improves, particularly MRI, and colonoscopy becomes routine, many rarer tumors are detected incidentally.Diligent linkage of clinical features with expert histopathology assessment identifies uncommon anal neoplasms to ensure that appropriate management is instituted.

AB - Anal cancer is a rare disease with epidermoid cancers accounting for 1% to 2% of all digestive tract malignancies.1Less common anal neoplasms comprise approximately 20% to 25% of these,2including anal canal adenocarcinoma, anorectal melanoma,mesenchymal and neurogenic tumors of the anal canal (in particular gastrointestinal stromal tumors [GIST], schwannomas, and sarcomas), neuroendocrine tumors (NETs),lymphoma, and basal cell carcinoma (BCC). The anal canal is also a rare site for metastasis from other primary malignancies. As imaging technology improves, particularly MRI, and colonoscopy becomes routine, many rarer tumors are detected incidentally.Diligent linkage of clinical features with expert histopathology assessment identifies uncommon anal neoplasms to ensure that appropriate management is instituted.

KW - Anal lymphoma

KW - Anal melanoma

KW - Anal neuroendocrine tumor

KW - Unusual cancers

UR - http://www.scopus.com/inward/record.url?scp=85006324374&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2016.07.009

DO - 10.1016/j.soc.2016.07.009

M3 - Review article

C2 - 27889033

AN - SCOPUS:85006324374

SN - 1055-3207

VL - 26

SP - 143

EP - 161

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

IS - 1

ER -

Uncommon Anal Neoplasms

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this